Advaxis

$0.2879
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0026 (-0.90%) Today

+$0.0026 (+0.91%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell Advaxis and other stocks, options, and ETFs commission-free!

About ADXS

Advaxis, Inc. Common Stock, also called Advaxis, is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. The listed name for ADXS is Advaxis, Inc. Common Stock.

CEO

Kenneth A. Berlin

Employees

Headquarters

Princeton, New Jersey

Founded

1987

Market Cap

18.89M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

7.80M

High Today

$0.308

Low Today

$0.2723

Open Price

$0.2966

Volume

8.57M

52 Week High

$1.48

52 Week Low

$0.2639

Collections

ADXS News

BenzingaNov 24

Why These 3 Pharma Stocks Are Moving Today

Alnylam Pharmaceuticals (NASDAQ: ALNY) shares are trading higher on Tuesday after the company announced its OXLUMO injection has received FDA approval for the t

BenzingaNov 24

Stocks That Hit 52-Week Lows On Tuesday

Before 10 a.m. ET Tuesday, 3 stocks hit new 52-week lows. Noteables: Tempur Sealy Intl (NYSE: TPX) was the largest firm on a market cap basis to set a new 52-

ADXS Earnings

-$1.32

-$0.88

-$0.44

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Dec 17, Pre-Market